Since time to surgery for lung cancer is not well established, researchers aimed to assess whether time to surgery from diagnosis correlates with outcomes like unplanned return to care, mortality, and disease recurrence.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
January 6, 2023
The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light.
Minimum Volume Standards for Surgical Care of Early-Stage Lung Cancer: A Cost-Effectiveness Analysis
December 21, 2022
This study aimed to determine the cost-effectiveness of receiving surgical resection for non-small cell lung cancer at hospitals that perform at least forty lung resections annually.
December 9, 2022
Researchers have been awarded a grant to fund cancer vaccine research, including the development of an mRNA vaccine that would target precancerous lung lesions.
December 9, 2022
This study aimed to measure the population-level impact of federal lung cancer screening recommendations and Medicare coverage. After these decisions were implemented, and when adjusted for age, researchers found that they were associated with an increased incidence of early-stage lung cancer and decreased incidence of advanced-stage lung cancer.
October 21, 2022
Because of the major developments in the treatment of esophageal cancer in recent decades, the authors of this study conducted it at a tertiary referral center to determine if long- and short-term survival rates had improved for patients who underwent esophagectomy from 1993 to 2018.
May 26, 2022
No statistical significance ,between the two arms, regarding the OVERALL survival in this RCT funded by the supplier and manufacturer of the immunotherapy in question....
January 27, 2021
An open-access detailed editorial from the official periodical of the International Association for the Study of Lung Cancer
November 21, 2020
A scholarly and sober narrative review on , as the authors state, a ' hot topic' that is already being debated in Multidisciplinary Meetings and Lung Cnacer Boards.
December 18, 2019
The PulMiCC is a randomized clinical trial that tried to build more evidence for performing pulmonary metastasectomy in patients affected by advanced colorectal cancer and previously treated with curative intent. Unfortunately, the trial was stopped earlier becasue of poor recruitment and high drop out rate.